Blog / News

October 10, 2018

Nic Sheff, author of “Tweak” and David Sheff, author of “Beautiful Boy” were joined Dr. Steven Shoptaw and Dr. Larissa Mooney of UCLA as part of the Friends of Semel screening of the upcoming film “Beautiful Boy” based on the family’s struggle with and recovery from addiction. The movie stars Steve Carell as David and Timothee Chalamet as Nic. After the film, the panel discussed issues of addiction.   Photos courtesy of Reed Hutchingson Photography.

August 16, 2018

In September 2017, the Drug Policy Alliance organized a conference in Los Angeles in partnership with over a dozen organizations, including the Center for Behavioral and Addiction Medicine (CBAM), titled “Stimulant Use: Harm Reduction, Treatment, and Future Directions.” The conference aimed to bring attention to a large class of drugs that has received inconsistent attention from the media, harm reduction and treatment communities, researchers, and policymakers alike. Los Angeles was chosen for this conference due…

August 1, 2018

We’re so excited to see the positive results of this program to assist federally qualified community health centers in the implementation of medication-assisted treatment (MAT) for opioid addiction. CBAM’s Dr. Keith Heinzerling was one of several MAT experts engaged by the program to provide direct coaching assistance to participating health centers. Program highlights include a shift in perspective about addiction and the use of MAT, as well as an increase in the number of patients…

April 6, 2018

A word from Dr. Steven Shoptaw: One of the world pioneers in HIV medicine in India was not only a physician scientist and inspiring human being, but apparently also a matchmaker! What is even better, is that Suniti continues to impact our world today when you look at this film trailer: lovesickthefilm.com Those of you privileged to have met Suniti Solomon will experience the same shock and thrill when you see her standing there, in…

March 9, 2018

Dr. Shoptaw traveled back to Cape Town, South Africa in February! While there, he met with our team at the University of Cape Town as they finish up a research project looking at the neuroscience behind contingency management for methamphetamine users. He also met with additional faculty at the University of Cape Town to discuss several exciting new research endeavors to expand our global efforts. We aim to bring the innovative, state-of-the-art interventions to Cape…

March 1, 2018

UCLA CBAM received a grant of $102,472 from the California Community Foundation to study the links between mental health and biological predictors of health outcomes in a cohort of primarily minority men who have sex with men (MSM) who are HIV positive. This is a population with low rates of viral suppression, a key measure of health outcomes for those affected by HIV. Viral suppression is an indicator, not only of overall health, but of…

February 23, 2018

CBAM’s Chris Blades attended the Los Angeles Community College District’s Transgender Summit at Los Angeles Trade Tech. The purpose of the summit was to share information, resources, and ideas to support transgender/gender-nonconforming individuals at the community colleges within Los Angeles County. Sessions at this summit focused on a variety of issues including internalized transphobia, how to empower LGBTQ youth, as well as cultural competency for businesses.

February 9, 2018

Staff from the UCLA Vine Street Clinic recently participated in a mural design project with the Hollywood Police Activities League (PAL) and Arts Bridging the Gap. PAL is a community-based program that provides youth with positive alternatives to drugs and crime. Arts Bridging the Gap also supports youth by linking together artists, educators, and community organizations to create meaningful and impactful art in the community. Our staff spent an afternoon brainstorming ideas with members of…

November 20, 2017

We cordially invite you to join the webinar introducing the Substance Use Measure Identification (SUMI) Tool. Dr. Shoptaw, Executive Committee Liaison for the Substance Use Scientific Committee SUSC worked in collaboration with Drs. Steffanie Strathdee and Nabila El-Bassel, and the SUSC to develop this tool to help researchers efficiently identify appropriate biomarker and behavioral survey measures to assess substance use in the context of HIV. Dr. Shipeng Chen designed and developed this tool. This collaboration,…

June 28, 2017

The UCLA Vine Street Clinic team is excited to be a part of on-going research testing the effectiveness of long-acting forms of HIV prevention medications. The current option, Truvada™ for PrEP (pre-exposure prophylaxis) requires that people take a pill every day, which can present barriers for many. There are two studies currently seeking to expand the options available for PrEP. The first is the AMP Study (Antibody Mediated Prevention). This is a new approach to…

June 21, 2017

CBAM would like to congratulate Dr. Walter Ling, 2017 recipient of the Nathan B. Eddy Memorial Award, acknowledging outstanding research efforts that have advanced knowledge of drug dependence. Dr. Ling’s research provided key information that led to the approval of many of the existing medication options for treating drug dependence. His illustrious career spans decades, covering groundbreaking research into the treatment of opioid, cocaine, and methamphetamine use disorders. His work has expanded to 15 countries…

April 20, 2017

Dr. Wilbert Jordan, Medical Director of the OASIS Clinic at Martin Luther King Jr. Outpatient Center and Associate Professor, Internal Medicine at Charles R. Drew University of Medicine and Science (CDU), recently announced that the OASIS Clinic has initiated biomedical services to prevent HIV. Pre-exposure Prophylaxis (PrEP) is one of the newest tools available in the HIV prevention toolbox. PrEP is a way for people who don’t have HIV but who are at very high…

February 1, 2017

CBAM works at the intersection of academia and community. We frequently publish findings from our research and collaborative projects with top scientific journals. Summaries of those articles are made available on our website so that everyone can see the fruits of our labor. In 2016, we covered a range of topics from HIV Stigma to integrating substance use care in primary health care settings. Read more here: http://www.uclacbam.org/about-us/publicationsresources/.

January 6, 2017

This lovely card arrived at the UCLA Vine Street Clinic over the holidays. It came from a patient who screened for one of our methamphetamine clinical trials. She was ultimately considered ineligible because of a medical condition, but the diagnosis she received here, prompted her to see her primary care physician. She wrote to let us know that, not only is her condition now under control, but that “My visits to your clinic were the…

December 22, 2016

Greetings from Vietnam! Dr. Shoptaw attended the workshop “Amphetamine-Type Stimulants (ATS) Workshop”, where he presented on “The Use of ATS and the Risk of HIV Infection in the United States: Some Models of Intervention.” Pictured here is Dr. Shoptaw (right) with Professor Robert Ali (left) from Australia and Professor Apinum Aramrattana (center) from Thailand.

December 21, 2016

  Although December signals the end of the year, we have been quite busy at CBAM. Members of the CHIPTS team at CBAM joined with community and government agencies to co-sponsor two local events. The City of Los Angeles AIDS Coordinator’s Office, in collaboration with several key community partners, hosted a conference on “Addressing the Intersection of Racism & HIV.” This event discussed important topics such as the role of mass incarceration in the spread…

September 29, 2016

Yesterday, a former research patient stopped by our clinic to drop off this cake as a token of appreciation, reporting 7 months of sobriety and counting. This is why we do the work we do at CBAM.

September 27, 2016

September 27 is National Gay Men’s HIV/AIDS Awareness Day. This day is a call to action to reduce the impact of HIV in the gay community. HIV disproportionately affects men who have sex with men – more so than any other group in the United States. Furthermore, HIV greatly affects communities of color within the men who have sex with men community. Young African-American men are the most disproportionately affected – it is estimated that…

September 20, 2016

This week, the UCLA Vine Street Clinic (UVSC) team hosted site visitors from the HIV Prevention Trials Network (HPTN). UVSC is one of 21 sites participating in the HPTN 085 trial, also known as the AMP (Antibody Mediated Prevention) study. This study will evaluate the safety, tolerability, and efficacy of the VRC01 antibody in preventing HIV-1 infection in healthy adults at high risk of HIV infection. Participants will be men who have sex with men…

July 26, 2016

CBAM is excited to report the success of the second all-grantee meeting for its Evaluation and Technical Assistance Center. Funded by HRSA’s Special Projects of National Significance and led by Dr. Ron Brooks, the focus of this center is “Use of Social Media to Improve Engagement, Retention, and Health Outcomes along the HIV Care Continuum Initiative.” The meeting was held at the Human Rights Campaign Foundation in Washington, D.C. The meeting aimed to provide information…

July 7, 2016

Charles R. Drew University of Medicine and Science will be hosting its 11th Drug Abuse Research Symposium on Friday, August 5, 2016 from 8:00am to 4:00 pm. The keynote speakers will be David Satcher, M.D., Ph.D., Founder and Senior Advisor, Satcher Health Leadership Institute, Morehouse School of Medicine, 16th US Surgeon General and Wilson Compton, M.D., M.P.E., Deputy Director, National Institute of Drug Abuse (NIDA). As part of the 11th Drug Abuse Research Symposium, we…

May 19, 2016

CBAM is excited to announce that we will be hosting a Fulbright Scholar this year. Dr. Brendan Quinn is a Research Officer in the Centre for Population Health at the Burnet Institute in Melbourne, Australia. He has been awarded the highly prestigious post-doctoral scholarship to work alongside Dr. Steven Shoptaw and his team in order to learn about our work with methamphetamine (MA) and how to engage MA users to reduce their use and other…

May 11, 2016

The Los Angeles County Commission On HIV and CHIPTS (Center for HIV Identification, Prevention and Treatment Services) invite you to attend “Igniting Conversation on HIV Treatment & Medication Adherence Through the Use of Telenovelas: Sin Vergüenza Season 2” Thursday, May 12 at St. Anne’s Maternity Home, 155 N. Occidental Boulevard, Los Angeles, CA 90026.

April 22, 2016

Alcohol Awareness Month, founded and sponsored by the National Council on Alcoholism and Drug Dependence (NCADD), has been in full swing during the month of April. This event aims to shed light on the stigma around alcohol by raising awareness, understanding, and knowledge of treatment options for those whose lives have been impacted by alcoholism. One key feature of their event is the Alcohol-Free Weekend. For one weekend, NCADD encourages people not to consume any…

April 15, 2016

In 2013, we profiled a young researcher. Ms. Annette Grotheer spent 10 weeks with CBAM as part of a NIDA-funded summer research program. She then finished her undergraduate degree and went on to graduate school at Tufts, where she designed and conducted a research project to track cases of cervical cancer in Kenya. After completing her research, Annie went on to complete further coursework in order to apply to medical school. She was recently accepted…

March 28, 2016

Dr. Steve Shoptaw, CBAM’s Executive Director, will be joining the editorial board of Drug and Alcohol Dependence (DAD). DAD is an international journal dedicated to publishing original research, scholarly reviews, commentaries, and policy analyses in the areas of drug, alcohol, and tobacco use and dependence. Dr. Shoptaw brings expertise garnered from over 25 years conducting Phase Ib and IIa randomized clinical trials of medications and behavioral interventions for stimulant-dependent individuals. He has produced over 180…

March 24, 2016

CBAM is pleased to congratulate our close colleague, Dr. Cathy Reback! Dr. Reback has been selected as one of the recipients of this year’s Women in Leadership Award from the City of West Hollywood for her outstanding work with gay and bisexual men and transgender women living with or at risk of acquiring HIV. She was presented with this prestigious award on Wednesday, March 23, 2016, hosted by the West Hollywood Women’s Advisory Board and…

March 2, 2016

CBAM’s Dr. Keith Heinzerling discusses the existing opioid addiction epidemic, how patients transition from prescription painkiller addiction to heroin/opioid addiction and the existing treatments available to combat opioid addiction. He also discusses how doctors and patients can work together to prevent addiction in patients with chronic pain.

February 12, 2016

We are excited to announce that our very own Dr. Steve Shoptaw has joined the UCLA AIDS Institute/CFAR Leadership group along with Dr. Pamina Gorbach. Together, they will lead the Biobehavioral Epidemiology and Substance Abuse Program Section. This will enable UCLA CFAR (Center for AIDS Research) to expand its presence into the field of HIV prevention and comorbidities, an emerging field of interest for the National Institutes of Health. The announcement was made at the…

February 4, 2016

The Safe Med LA Coalition is a countywide coalition dedicated to comprehensively addressing prescription drug abuse. The Coalition is currently focusing on expanding access to medication-assisted treatments (MAT) for addiction including, but not limited to, buprenorphine (Suboxone) and injectable naltrexone (Vivitrol). As part of the coalition, a MAT Expansion Action Team has been formed, which is being led by CBAM’s Dr. Keith Heinzerling, along with Drs. Gary Tsai and Brian Hurley. This MAT Action Team…

February 4, 2016

  On Monday, February 1, CBAM and the Behavioral Epidemiology Research Group hosted an all-day meeting titled “Advancing the Field of Biobehavioral Substance Use Measurement for HIV Positive and At-risk Populations”. The day was sponsored by UCLA CFAR and the AIDS Institute, with additional support from UCLA CHIPTS. The meeting was a rousing success, with representatives from our very own UCLA, Columbia University, John Hopkins University, Northwestern University, University of Maryland, University of Washington, UCSD,…

January 23, 2016

This HPTN 073 writing retreat held on the campus of the Melvyn Dymally School of Nursing at Charles R Drew University gathered protocol leaders, site leaders, Black Caucus members, lab and data leaders, and advocates together on Jan 19-20. At the retreat the 073 team reviewed the first cut of findings from HPTN 073 in preparation for presentations at conferences and for manuscripts. Steve Shoptaw, Christopher Hucks Ortiz and Dean Sheldon Fields represented Los Angeles…

December 30, 2015

As another year comes to a close, we wanted to share just a few highlights from 2015. • CBAM formed a new collaboration with the University of Cape Town through a NIDA-funded study linking findings from neuroscience with clinical outcomes using contingency management to identify changes in the brain structure and function of methamphetamine users that emerge during purely behavioral therapy. • Our Executive Director, Dr. Steven Shoptaw, gave a well-received talk on non-injection drug…

December 2, 2015

On World AIDS Day 2015, there is some risk in resting on the considerable successes in treatment AND prevention of HIV. The capacity to treat HIV using one or two tablets per day changed a disease that many called a “death sentence” to being a chronic illness that can be controlled with daily medication, similar to Type II diabetes. Strong scientific evidence shows that the risks for transmitting HIV to ones’ sexual partners are low…

November 30, 2015

November 30 is National Meth Awareness Day and the UCLA Center for Behavioral and Addiction Medicine (CBAM) would like to shed light on an epidemic that affects roughly 1.2 million people in the United States alone. Methamphetamine is a stimulant that affects the central nervous system and causes high levels of dopamine to be released in the brain. Dopamine is a neurotransmitter that has many functions, one of which is to make people feel “good”,…

November 20, 2015

The Food & Drug Administration has approved a nasal spray for opioid overdose. In their release, they state: Today the U.S. Food and Drug Administration approved Narcan nasal spray, the first FDA-approved nasal spray version of naloxone hydrochloride, a life-saving medication that can stop or reverse the effects of an opioid overdose. Opioids are a class of drugs that include prescription medications such as oxycodone, hydrocodone, and morphine, as well as the illegal drug heroin.…

November 14, 2015

mSTUDY (MSM and Substances Cohort at UCLA Linking Infections Noting Effects), is a UCLA-based cohort of substance using minority (Black or Latino) men who have sex with men (MMSM). Of these, about one-half are HIV-positive; the other half are HIV-negative MMSM at high-risk for HIV acquisition. When at full size, this cohort will comprise 620 MMSM with repeated data visits spaced every six months from an enrolled cohort of 1,080 MMSM. It provides a well-characterized,…

October 9, 2015

Despite an overall decline in new HIV diagnoses among Latinos, there has been a sharp increase in diagnoses among Latino men who have sex with men (MSM).

September 25, 2015

September 27 is National Gay Men’s HIV/AIDS Awareness Day. Despite advances in behavioral and biomedical interventions, HIV infection remains a persistent problem in the United States with an estimated 50,000 new infections annually. The transmission of HIV continues to significantly impact men who have sex with men (MSM) in the United States, representing 63% of all new infections in 2010, with minority MSM bearing the heaviest burden. In Los Angeles County (LAC), surveillance data from…

August 27, 2015

CBAM participates each year in NIDA’s summer intern program for underrepresented minority students. One of this year’s interns, Sergio, is a recent graduate of California State University, Long Beach with a Bachelor’s degree in psychology. We sat down with him to learn more about his interests. What drew you to studying psychology? Just the science itself. It’s a very interesting field. There’s so much in it, and it’s so philosophical and artistic at the same…

About

CBAM is a multidisciplinary center that seeks to advance the prevention and treatment of chronic illnesses, especially in communities with health disparities. As part of the UCLA Department of Family Medicine, CBAM works at the intersection of academia and community with a focus on treating addictions and preventing the spread of HIV.

© The UCLA Center for Behavioral & Addiction Medicine (CBAM). All Rights Reserved.